Literature DB >> 19429887

Colocalization of prostaglandin F(2alpha) receptor FP and prostaglandin F synthase-I in the spinal cord.

T Suzuki-Yamamoto1, K Toida, Y Sugimoto, K Ishimura.   

Abstract

Prostaglandin F(2alpha) is synthesized by prostaglandin F synthase, which exists in two types, prostaglandin F synthase I (PGFS I) and prostaglandin F synthase II (PGFS II). Prostaglandin F(2alpha) binds to its specific receptor, FP. Our previous immunohistochemical study showed the distinct localization of prostaglandin F synthases in rat spinal cord. PGFS I exists in neuronal somata and dendrites in the gray substance, and PGFS II exists in ependymal cells and tanycytes surrounding the central canal. Both enzymes are also present in endothelial cells of blood vessels in the white and gray substances of the spinal cord. In this study, we found that FP localizes in neuronal somata and dendrites but not in ependymal cells, tanycytes, or endothelial cells. Immunohistochemical analysis of serial sections showed the colocalization of FP and PGFS I. FP immunoreactivity was intense in spinal laminae I and II of the dorsal horn, a connection site of pain transmission, and was similar to that of PGFS I in neuronal elements. These findings suggest that prostaglandin F(2alpha) synthesized in the neuronal somata and dendrites exert an autocrine action there.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429887      PMCID: PMC2739758          DOI: 10.1194/jlr.M800543-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  26 in total

1.  Immunocytochemical localization of prostaglandin F synthase II in the rat spinal cord.

Authors:  T Suzuki-Yamamoto; K Toida; K Watanabe; K Ishimura
Journal:  Brain Res       Date:  2003-04-18       Impact factor: 3.252

2.  Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.

Authors:  Peter Teismann; Kim Tieu; Dong-Kug Choi; Du-Chu Wu; Ali Naini; Stéphane Hunot; Miquel Vila; Vernice Jackson-Lewis; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

3.  PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis.

Authors:  Masako Bilak; Liejun Wu; Qian Wang; Norman Haughey; Katherine Conant; Coryse St Hillaire; Katrin Andreasson
Journal:  Ann Neurol       Date:  2004-08       Impact factor: 10.422

4.  Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.

Authors:  N Eguchi; T Kaneko; Y Urade; H Hayashi; O Hayaishi
Journal:  J Pharmacol Exp Ther       Date:  1992-09       Impact factor: 4.030

5.  Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.

Authors:  Daniel B Drachman; Krystl Frank; Margaret Dykes-Hoberg; Peter Teismann; Gabrielle Almer; Serge Przedborski; Jeffrey D Rothstein
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

6.  Functional characterization of prostaglandin F2alpha receptor in the spinal cord for tactile pain (allodynia).

Authors:  Tadatoshi Muratani; Mikio Nishizawa; Shinji Matsumura; Tamaki Mabuchi; Kohji Abe; Keiko Shimamoto; Toshiaki Minami; Seiji Ito
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

7.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

8.  Modulatory effects of prostaglandin D2, E2 and F2 alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro.

Authors:  H Kimura; K Okamoto; Y Sakai
Journal:  Brain Res       Date:  1985-03-25       Impact factor: 3.252

9.  Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra.

Authors:  Z-H Feng; T-G Wang; D-D Li; P Fung; B C Wilson; B Liu; Syed F Ali; R Langenbach; J-S Hong
Journal:  Neurosci Lett       Date:  2002-09-06       Impact factor: 3.046

10.  Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase.

Authors:  K Watanabe; Y Iguchi; S Iguchi; Y Arai; O Hayaishi; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more
  3 in total

Review 1.  Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.

Authors:  Najam A Sharif; Peter G Klimko
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

Review 2.  Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors.

Authors:  Najam A Sharif
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 3.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.